CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 900 enrolled
Drug / intervention
Ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06829121
NCT06829121N/ACompleted

Ultrasound-based Morphometry for the Development of Diagnostic and Prognostic Markers in Current and Chronic Diseases

Universitatsmedizin Mainz - 1. Medizinische Klinik·observational·Posted Feb 17, 2025·Updated Feb 17, 2025

In Brief

An observational study evaluating Ultrasound for Ultrasound and 2 related conditions. Completed, enrolled 900 participants across 1 site.

Detailed Summary

Frailty or debility is a geriatric syndrome that primarily affects older patients, but also patients with severe illnesses. It is particularly common among oncology patients, but also among patients with gastrointestinal diseases such as liver cirrhosis or pancreatitis. Sarcopenia, a component of frailty, is defined as a loss of muscle quantity, quality and function. Currently, complex methods such as CT or bioimpedance measurement are available. However, simpler techniques such as ultrasound-based measurement could be alternatives, but require further validation. The aim of this project is to be able to estimate the prognosis of patients at an early stage by measuring sarcopenia using sonography.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 17, 2025
Enrollment StartOct 1, 2020
Primary CompletionMay 20, 2022
Study CompletionDec 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 1.4 years ago

Interventions

Ultrasoundother

The thickness of the psoas muscle and the musculus quadriceps femoris will be measured by ultrasound